BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26526215)

  • 1. Geographic trends in management of early-stage laryngeal cancer.
    Mourad M; Dezube A; Moshier E; Shin E
    Laryngoscope; 2016 Apr; 126(4):880-4. PubMed ID: 26526215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival outcomes in advanced laryngeal cancer.
    Megwalu UC; Sikora AG
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year survival rates and time trends of laryngeal cancer in the US population.
    Cosetti M; Yu GP; Schantz SP
    Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma.
    Brady JS; Marchiano E; Kam D; Baredes S; Eloy JA; Park RC
    Otolaryngol Head Neck Surg; 2016 Aug; 155(2):257-64. PubMed ID: 27026735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laryngeal Papillary Squamous Cell Carcinoma: A Population-Based Analysis of Incidence and Survival.
    Dutta R; Husain Q; Kam D; Dubal PM; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Jul; 153(1):54-9. PubMed ID: 25917664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in laryngeal cancer treatment and outcome: A population-based analysis of 24,069 patients.
    Shin JY; Truong MT
    Laryngoscope; 2015 Jul; 125(7):1667-74. PubMed ID: 25694265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.
    Hoffman HT; Porter K; Karnell LH; Cooper JS; Weber RS; Langer CJ; Ang KK; Gay G; Stewart A; Robinson RA
    Laryngoscope; 2006 Sep; 116(9 Pt 2 Suppl 111):1-13. PubMed ID: 16946667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in survival outcome between stage I and stage II glottic cancer: A SEER-based analysis.
    Chen JJ; Stessin A; Christos P; Wernicke AG; Nori D; Parashar B
    Laryngoscope; 2015 Sep; 125(9):2093-8. PubMed ID: 26109043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subglottic Squamous Cell Carcinoma: A Population-Based Study of 889 Cases.
    Marchiano E; Patel DM; Patel TD; Patel AA; Xue YE; Eloy JA; Baredes S; Park RC
    Otolaryngol Head Neck Surg; 2016 Feb; 154(2):315-21. PubMed ID: 26607281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
    Chen AY; Fedewa S; Zhu J
    Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1017-24. PubMed ID: 22006780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and prognostic indicators in laryngeal lymphoma: A population-based analysis.
    Hong SA; Tajudeen BA; Choi S; Husain IA
    Laryngoscope; 2018 Sep; 128(9):2044-2049. PubMed ID: 29392765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal adenosquamous carcinoma: A population-based perspective.
    Dubal PM; Unsal AA; Echanique KA; Vazquez A; Reder LS; Baredes S; Eloy JA
    Laryngoscope; 2016 Apr; 126(4):858-63. PubMed ID: 26452061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laryngeal spindle cell carcinoma: A population-based analysis of incidence and survival.
    Dubal PM; Marchiano E; Kam D; Dutta R; Kalyoussef E; Baredes S; Eloy JA
    Laryngoscope; 2015 Dec; 125(12):2709-14. PubMed ID: 25994520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laryngeal Verrucous Carcinoma: A Population-Based Analysis.
    Dubal PM; Svider PF; Kam D; Dutta R; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):799-805. PubMed ID: 26124268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraglottic Squamous Cell Carcinoma: A Population-Based Study of 22,675 Cases.
    Patel TD; Echanique KA; Yip C; Hsueh WD; Baredes S; Park RCW; Eloy JA
    Laryngoscope; 2019 Aug; 129(8):1822-1827. PubMed ID: 30536822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients.
    Zhang H; Travis LB; Chen R; Hyrien O; Milano MT; Newlands SD; Chen Y
    Cancer; 2012 Mar; 118(5):1276-87. PubMed ID: 21773970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laryngeal Neuroendocrine Carcinoma: A Population-Based Analysis of Incidence and Survival.
    Ghosh R; Dutta R; Dubal PM; Park RC; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Dec; 153(6):966-72. PubMed ID: 26183520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery versus radiation for T1 glottic carcinoma: Second primary considerations.
    Puram SV; Bhattacharyya N
    Laryngoscope; 2019 Dec; 129(12):2713-2715. PubMed ID: 30767222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.